- Shares of Ziopharm Oncology (ZIOP +18.2%) post double-digit gains.
- The company presented today at the Biotech Industry Conference in New York.
- In the presentation, ZIOP says it is "the farthest advanced at regulating gene function in vivo in humans" and notes that it expects to have "at least 8 INDs through 2015."
- The company also says data is set to be presented "near-term" at multiple conferences. (full presentation)
Ziopharm Oncology shares rally, company presents at conference
From other sites
at CNBC.com (Jan 16, 2015)
at CNBC.com (Feb 14, 2013)
at CNBC.com (Jul 20, 2011)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs